The multicenter clinical test which considers predictive risk factors of acute kidney injury after chemotherapy including cisplatinun

The multicenter clinical test which considers predictive risk factors of acute kidney injury after chemotherapy including cisplatinun - predictive risk factors of AKI after chemotherapy including CDPP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023553

Enrollment

Registered

2016-10-01

Start date

2016-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urothelial cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with urothelial cancer with chemotherapy including CDDP first-pearson informed consent

Exclusion criteria

Exclusion criteria: patient with maintenance HD therapy

Design outcomes

Primary

Measure	Time frame
the presence or absence of AKI after CDDP chemotherapy	—

Secondary

Measure	Time frame
the predictive risk factors of AKI after chemotherapy including CDDP	—

Countries

Japan

Contacts

Public ContactSATORU MUTO

Teikyo Universith School of Medicine Department of Urology

urology@med.teikyo-u.ac.jp0339641211

Outcome results